Reaktion #534

ord-9f41dcdcc0414ae7bc18304ff07e7d77

Reaktionsgleichung

Fc1cc(F)cc(Br)c1
Fc1cc(F)cc(Br)c1
COC(=O)c1cc(C2CCCN2)c2oc(N3CCOCC3)cc(=O)c2c1
COC(=O)c1cc(C2CCCN2)
COC(=O)c1cc(C2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1
COC(=O)c1cc(C2CCCN2c
Ausbeute 66.2%

Lösungsmittel

Reaktionsbedingungen

Temperatur
100°CELSIUS

Vorschrift

diacetoxypalladium (0.020 g, 0.09 mmol) was added to a stirred mixture of methyl 2-morpholino-4-oxo-8-(pyrrolidin-2-yl)-4H-chromene-6-carboxylate (0.8g, 2.23 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (0.110 g, 0.19 mmol), 1-bromo-3,5-difluorobenzene (0.321 ml, 2.79 mmol) and cesium carbonate (1.091 g, 3.35 mmol) suspended in 1,4-dioxane (22.00 ml). The resulting suspension was degased with argon and then stirred at 100 °C for 20 hours. _maybe not complete but have to go forward_ The reaction mixture was allowed to cool to room temperature, the insoluble were removed by filtration and the filtrate concentrated. The crude product was adsorbed on silica gel and purified by flash chromatography on silica gel eluting with 0 to 6% methanol in ethyl acetate. The solvent was evaporated to dryness to afford methyl 8-(1-(3,5-difluorophenyl)pyrrolidin-2-yl)-2-morpholino-4-oxo-4H-chromene-6-carboxylate (0.760 g, 66.2 %) as a beige foam.

Quelle

750 AstraZeneca ELN dataset